Nifty
Sensex
:
:
24221.90
80109.85
314.65 (1.32%)
992.74 (1.25%)

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 500288 | NSE: MOREPENLAB

58.92
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  55.82
  •  59.79
  •  55.75
  •  55.82
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  21702940
  •  12700.95
  •  100.90
  •  38.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,055.95
  • 30.89
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,034.07
  • N/A
  • 3.65

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 35.65%
  • 3.47%
  • 48.16%
  • FII
  • DII
  • Others
  • 2.08%
  • 0.95%
  • 9.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.48
  • 14.66
  • 3.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.64
  • 18.28
  • 3.02

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 46.30
  • 23.42
  • -1.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.51
  • 26.45
  • 30.78

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.94
  • 3.45
  • 2.93

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.61
  • 15.44
  • 16.47

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
437.73
421.77
3.78%
455.22
401.04
13.51%
423.07
363.69
16.33%
444.55
348.47
27.57%
Expenses
393.66
388.18
1.41%
403.60
374.95
7.64%
374.69
348.13
7.63%
393.99
327.94
20.14%
EBITDA
44.07
33.59
31.20%
51.62
26.09
97.85%
48.38
15.56
210.93%
50.57
20.52
146.44%
EBIDTM
10.07%
7.96%
11.34%
6.51%
11.44%
4.28%
11.37%
5.89%
Other Income
4.99
3.24
54.01%
3.43
2.42
41.74%
4.24
3.12
35.90%
4.07
1.22
233.61%
Interest
1.18
0.46
156.52%
1.15
0.28
310.71%
0.80
0.56
42.86%
2.17
0.55
294.55%
Depreciation
1.86
7.69
-75.81%
5.73
7.71
-25.68%
9.62
6.98
37.82%
8.45
7.19
17.52%
PBT
46.02
28.68
60.46%
48.17
20.51
134.86%
42.20
11.14
278.82%
44.02
14.00
214.43%
Tax
11.17
7.43
50.34%
12.00
5.88
104.08%
13.46
2.90
364.14%
12.03
5.01
140.12%
PAT
34.85
21.26
63.92%
36.17
14.63
147.23%
28.74
8.24
248.79%
31.99
8.99
255.84%
PATM
7.96%
5.04%
7.95%
3.65%
6.79%
2.27%
7.20%
2.58%
EPS
0.64
0.42
52.38%
0.71
0.29
144.83%
0.55
0.16
243.75%
0.63
0.18
250.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,760.57
1,690.43
1,417.53
1,546.83
1,188.06
853.07
768.54
606.51
595.47
485.08
400.64
Net Sales Growth
14.70%
19.25%
-8.36%
30.20%
39.27%
11.00%
26.72%
1.85%
22.76%
21.08%
 
Cost Of Goods Sold
1,081.47
1,016.87
900.22
980.35
735.29
524.19
479.12
361.28
358.35
293.33
238.62
Gross Profit
679.10
673.56
517.31
566.47
452.77
328.87
289.42
245.23
237.12
191.76
162.02
GP Margin
38.57%
39.85%
36.49%
36.62%
38.11%
38.55%
37.66%
40.43%
39.82%
39.53%
40.44%
Total Expenditure
1,565.94
1,531.81
1,338.00
1,410.15
1,069.54
784.55
701.02
541.78
534.09
423.52
352.41
Power & Fuel Cost
-
34.09
23.78
18.93
13.00
12.56
13.18
11.08
9.84
7.64
7.41
% Of Sales
-
2.02%
1.68%
1.22%
1.09%
1.47%
1.71%
1.83%
1.65%
1.57%
1.85%
Employee Cost
-
181.47
154.68
164.25
135.59
109.91
95.36
76.53
69.69
58.29
48.79
% Of Sales
-
10.74%
10.91%
10.62%
11.41%
12.88%
12.41%
12.62%
11.70%
12.02%
12.18%
Manufacturing Exp.
-
95.75
91.70
98.99
67.21
48.92
31.28
16.21
22.36
13.33
12.68
% Of Sales
-
5.66%
6.47%
6.40%
5.66%
5.73%
4.07%
2.67%
3.76%
2.75%
3.16%
General & Admin Exp.
-
66.63
55.44
42.38
34.71
36.47
36.14
28.52
18.11
18.14
15.89
% Of Sales
-
3.94%
3.91%
2.74%
2.92%
4.28%
4.70%
4.70%
3.04%
3.74%
3.97%
Selling & Distn. Exp.
-
109.98
93.01
53.58
49.66
40.11
32.73
30.04
25.79
23.45
21.40
% Of Sales
-
6.51%
6.56%
3.46%
4.18%
4.70%
4.26%
4.95%
4.33%
4.83%
5.34%
Miscellaneous Exp.
-
27.02
19.17
51.67
34.08
12.39
13.20
18.11
29.95
9.35
21.40
% Of Sales
-
1.60%
1.35%
3.34%
2.87%
1.45%
1.72%
2.99%
5.03%
1.93%
1.90%
EBITDA
194.64
158.62
79.53
136.68
118.52
68.52
67.52
64.73
61.38
61.56
48.23
EBITDA Margin
11.06%
9.38%
5.61%
8.84%
9.98%
8.03%
8.79%
10.67%
10.31%
12.69%
12.04%
Other Income
16.73
13.97
6.13
20.10
12.07
9.48
3.67
3.72
3.72
1.20
1.37
Interest
5.30
3.71
1.98
2.43
1.79
1.98
2.11
4.36
7.56
10.50
8.66
Depreciation
25.66
33.47
27.93
27.64
30.28
36.91
39.90
34.32
33.90
35.20
38.67
PBT
180.41
135.42
55.76
126.70
98.51
39.11
29.18
29.77
23.63
17.06
2.28
Tax
48.66
38.80
17.08
25.02
1.42
5.53
0.34
0.00
0.00
-0.13
0.14
Tax Rate
26.97%
28.65%
30.63%
19.75%
1.44%
14.14%
1.17%
0.00%
0.00%
-1.03%
6.14%
PAT
131.75
96.16
38.68
101.68
97.09
33.58
28.85
29.59
23.63
12.80
2.14
PAT before Minority Interest
131.75
96.62
38.68
101.68
97.09
33.58
28.84
29.77
23.63
12.80
2.14
Minority Interest
0.00
-0.46
0.00
0.00
0.00
0.00
0.01
-0.18
0.00
0.00
0.00
PAT Margin
7.48%
5.69%
2.73%
6.57%
8.17%
3.94%
3.75%
4.88%
3.97%
2.64%
0.53%
PAT Growth
148.02%
148.60%
-61.96%
4.73%
189.13%
16.40%
-2.50%
25.22%
84.61%
498.13%
 
EPS
2.40
1.75
0.71
1.86
1.77
0.61
0.53
0.54
0.43
0.23
0.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
847.23
752.91
578.56
424.75
284.06
253.09
225.94
196.26
300.28
287.48
Share Capital
102.23
102.23
95.56
89.96
89.96
89.96
89.96
89.96
209.61
209.61
Total Reserves
745.00
650.68
456.75
291.04
194.10
163.13
135.98
106.30
90.67
77.87
Non-Current Liabilities
43.93
36.88
35.50
30.06
28.42
23.38
20.20
17.80
57.47
74.00
Secured Loans
3.36
0.93
1.32
0.83
0.92
1.83
2.95
1.38
43.41
62.27
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
33.82
29.74
28.24
25.39
23.82
19.01
14.42
13.59
11.34
9.22
Current Liabilities
402.04
321.16
456.46
403.80
351.44
339.17
340.12
324.86
166.56
127.92
Trade Payables
295.03
226.88
258.12
208.85
172.30
168.15
174.88
124.88
115.33
84.96
Other Current Liabilities
58.51
54.86
169.97
174.38
165.06
160.64
163.90
198.65
47.04
39.87
Short Term Borrowings
23.49
23.18
16.13
15.32
11.36
8.99
0.00
0.00
0.00
2.23
Short Term Provisions
25.02
16.24
12.24
5.25
2.72
1.39
1.33
1.33
4.19
0.86
Total Liabilities
1,293.20
1,110.49
1,070.06
858.15
663.46
615.18
585.81
538.29
523.68
489.00
Net Block
307.35
266.97
251.80
224.52
216.37
236.21
264.29
271.80
296.72
322.48
Gross Block
620.63
656.24
613.25
628.32
752.55
887.76
997.60
1,026.96
1,018.43
1,009.35
Accumulated Depreciation
313.28
389.27
361.45
403.79
536.18
651.55
733.31
755.15
721.72
686.87
Non Current Assets
404.16
354.33
335.75
331.36
291.29
315.71
342.37
346.34
366.53
374.42
Capital Work in Progress
24.45
17.01
14.15
1.96
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investment
1.30
0.00
0.00
1.08
1.08
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
70.82
70.07
69.53
103.52
73.55
79.22
77.81
73.69
69.82
51.94
Other Non Current Assets
0.24
0.28
0.28
0.27
0.28
0.28
0.27
0.85
0.00
0.00
Current Assets
889.04
756.16
734.30
526.79
372.18
299.47
243.44
191.95
157.15
114.58
Current Investments
0.00
0.00
0.00
0.00
0.00
0.02
0.22
0.00
0.00
0.00
Inventories
248.59
228.89
275.85
175.33
138.48
94.20
76.89
64.66
42.14
37.11
Sundry Debtors
324.94
263.25
250.64
181.98
137.68
133.75
121.85
92.95
87.94
56.14
Cash & Bank
52.12
56.31
45.97
67.89
38.88
32.21
5.95
7.59
4.36
8.85
Other Current Assets
263.40
7.15
5.29
10.01
57.14
39.29
38.54
26.74
22.71
12.48
Short Term Loans & Adv.
246.96
200.58
156.54
91.58
51.16
31.43
32.92
22.03
16.77
9.34
Net Current Assets
487.00
435.00
277.84
122.99
20.73
-39.70
-96.68
-132.92
-9.41
-13.34
Total Assets
1,293.20
1,110.49
1,070.05
858.15
663.47
615.18
585.81
538.29
523.68
489.00

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
73.37
-91.17
-60.24
50.83
11.02
17.37
63.41
40.73
50.07
50.70
PBT
135.42
55.76
126.70
98.51
39.11
29.18
29.77
23.04
17.06
2.28
Adjustment
34.20
27.90
19.46
31.96
36.63
40.32
38.64
41.40
45.69
47.32
Changes in Working Capital
-58.12
-158.28
-181.47
-78.18
-58.84
-51.78
-5.00
-23.72
-8.41
1.23
Cash after chg. in Working capital
111.49
-74.62
-35.31
52.29
16.89
17.71
63.41
40.73
54.34
50.83
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-38.12
-16.55
-24.93
-1.46
-5.88
-0.34
0.00
0.00
0.13
-0.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-4.40
0.00
Cash From Investing Activity
-83.30
-46.51
-31.68
-70.35
-12.46
-13.05
-26.93
-13.60
-27.30
-31.65
Net Fixed Assets
27.27
-35.47
24.52
123.41
135.60
113.16
31.96
-8.08
-7.02
-4.73
Net Investments
-8.34
-0.05
0.99
0.00
-1.07
0.20
-0.22
0.00
0.25
0.00
Others
-102.23
-10.99
-57.19
-193.76
-146.99
-126.41
-58.67
-5.52
-20.53
-26.92
Cash from Financing Activity
5.20
143.54
66.33
47.27
5.49
-0.44
-37.77
-23.72
-27.26
-19.31
Net Cash Inflow / Outflow
-4.72
5.86
-25.58
27.75
4.04
3.88
-1.29
3.40
-4.49
-0.26
Opening Cash & Equivalents
21.67
15.80
41.39
13.64
9.60
5.72
7.00
3.60
8.85
9.11
Closing Cash & Equivalent
16.95
21.67
15.80
41.39
13.64
9.60
5.72
7.00
4.36
8.85

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
16.58
14.73
11.56
8.47
6.32
5.63
5.02
4.36
4.02
3.73
ROA
8.04%
3.55%
10.55%
12.76%
5.25%
4.80%
5.30%
4.45%
2.53%
0.44%
ROE
12.08%
5.93%
21.79%
29.20%
12.50%
12.04%
14.10%
12.54%
7.35%
1.24%
ROCE
16.82%
8.40%
24.86%
27.13%
12.05%
10.01%
14.05%
10.18%
6.29%
2.90%
Fixed Asset Turnover
2.65
2.23
2.49
1.72
1.04
0.82
0.60
0.58
0.49
0.41
Receivable days
63.50
66.16
51.04
49.10
58.07
60.70
64.63
55.44
53.22
44.17
Inventory Days
51.55
64.98
53.23
48.20
49.78
40.63
42.59
32.73
29.27
31.48
Payable days
93.67
98.32
86.93
94.60
79.06
88.85
103.38
82.97
83.88
76.01
Cash Conversion Cycle
21.38
32.82
17.35
2.71
28.78
12.48
3.85
5.20
-1.39
-0.36
Total Debt/Equity
0.03
0.03
0.03
0.04
0.05
0.52
0.06
0.25
0.22
0.28
Interest Cover
37.50
29.15
53.22
56.09
20.71
14.83
7.83
4.13
2.21
1.26

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.